Source: Sharecast
Entain and NatWest were both weaker as they traded without entitlement to the dividend.
Halma jumped after saying it expects an adjusted EBIT margin modestly above 21% for the full year to March 2025, compared to prior guidance of around 21%.
Matt Britzman, senior equity analyst at Hargreaves Lansdown, said: "Halma, a FTSE 100 leader in life-saving technologies, has delivered yet another robust trading update, putting it firmly on course for an impressive 22nd consecutive year of record profits.
"Despite navigating tricky economic and geopolitical conditions, Halma’s resilient business model and agile operations mean margins are better than expected, and that should mean profit expectations for the year can tick higher.
"In today’s volatile environment, steady and dependable businesses like Halma - while not always headline-grabbing - offer investors an attractive blend of quality and reliability when it’s needed the most."
FTSE 100 - Risers
Vodafone Group (VOD) 72.66p 3.71%
Antofagasta (ANTO) 1,791.00p 1.85%
Halma (HLMA) 2,687.00p 1.78%
Airtel Africa (AAF) 149.40p 1.70%
AstraZeneca (AZN) 11,842.00p 1.65%
Imperial Brands (IMB) 2,779.00p 1.53%
Shell (SHEL) 2,605.00p 1.42%
BT Group (BT.A) 154.75p 1.31%
Aviva (AV.) 545.20p 1.23%
Rentokil Initial (RTO) 323.20p 1.00%
FTSE 100 - Fallers
Entain (ENT) 627.80p -3.27%
Coca-Cola HBC AG (CDI) (CCH) 3,364.00p -3.22%
Hiscox Limited (DI) (HSX) 1,114.00p -3.05%
Melrose Industries (MRO) 502.80p -2.93%
Diploma (DPLM) 3,956.00p -2.80%
NATWEST GROUP (NWG) 434.60p -2.58%
Intertek Group (ITRK) 4,868.00p -2.52%
Croda International (CRDA) 3,102.00p -2.51%
Persimmon (PSN) 1,164.00p -2.51%
Hikma Pharmaceuticals (HIK) 2,020.00p -2.51%